Øystein, Soug (Polaris 201506 announced as CFO before Algeta + Orcla) |
Chief Financial Officer (CFO) |
Polaris (NO) (Group) |
Norway |
Østergaard, Simon (Agilent 202003 VP + General Manager Pathology Group) |
General Manager (management) |
Agilent (Group) |
United States (USA) |
Østergaard, Jes (DakoCytomation 200506 CEO) |
Chief Executive Officer (CEO) |
Agilent (Group) |
Denmark |
Ørum, Henrik (Santaris Pharma 200712 CSO + VP BusDev) |
Business Development Manager / Strategy Manager |
Roche (Group) |
Denmark |
Ørnskov, Flemming (Shire 201301– CEO before Bayer Chief Marketing Officer + Bausch & Lomb + Ikaria + Novartis) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Ireland, Republic of |
Žunda, Giedrius (Northway 201812– CEO of Biotechpharma UAB before Sicor Biotech UAB/Teva since 2002) |
Chief Executive Officer (CEO) |
Northway (Group) |
Lithuania |
Žmuc, Dora (Patronus Health 202204 Managing Director + Chief Business Development Officer + Co-Founder) |
Business Development Manager / Strategy Manager |
Patronus Health GmbH |
Germany |
Šušteric, Jakob (MESI 202306 CEO) |
Chief Executive Officer (CEO) |
MESI (Group) |
Slovenia |
Štrancar, Aleš (BIA Separations 201309 CEO + Chief Business Development Officer) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Slovenia |
Špíšek, Radek (PPF Group 201803– CEO of Sotio + Prof at Charles Univ Prague) |
Chief Executive Officer (CEO) |
PPF Group (Group) |
Czech Republic |
Šakalys, Vidmantas (Vital 3D technologies 202403 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Vital 3D Technoloiges (Vital3D) (LT) |
Lithuania |
Özbal, Can (PureHoney Technologies 2014– CEO + Co-Founder before BIOCIUS + BioTrove) |
Chief Operating Officer (COO) |
PureHoney Technologies (US) |
United States (USA) |
Östros, Thomas (EU (govt) 202010 VP of EIB) |
President/Director/Head Business Group/Unit/Division |
EU (govt) |
Luxembourg |
Ölschläger, Uwe (Qiagen 200904) |
n. a. |
Qiagen (Group) |
Germany |
Öhrström, Jan (VarmX 202305 CEO formerly ProFibrix + ZymoGenetics + Novo Nordisk) |
Chief Executive Officer (CEO) |
VarmX B.V. |
Netherlands |
Öhrn, Iris (Business Region Göteborg 201211 Investment Manager Life Sciences) |
Cluster Manager |
Göteborg Bio – Business Region Göteborg AB |
Sweden |
Öhman, Ove (Åmic 200806 CEO + founder) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
Sweden |
Öhman, Lars (Immunscape 201609 CEO) |
Chief Executive Officer (CEO) |
Immunscape AB |
Sweden |
Åström, Håkan |
Board member |
Affibody Medical AB |
Sweden |
Åmark, Martin (Xbrane 2020 CEO9 |
Chief Executive Officer (CEO) |
Xbrane (Group) |
Sweden |
Åberg, Anders (Sprint Bioscience 2009–201906 CEO + Co-Founder RESIGNED 6/19) |
Chief Executive Officer (CEO) |
Sprint Bioscience AB |
Sweden |
Zörgiebel, Wilhelm (Willi) (Biotype Diagnostic 201107 Managing Director + Owner before Priontype) |
Managing Director |
Qiagen (Group) |
Germany |
Zöllner, E. Jürgen (Stiftung Charité 201209 Board Member) |
n. a. |
Stiftung Charité |
Germany |
Zöchbauer, Emmerich (BIA Separations 201509 Chair Board of BIA Separations Austria) |
Board member, executive |
Sartorius (Group) |
Austria |
Zätzsch, Jörg (CMS Hasche Sigle 200809 Berlin) |
Attorney / Lawyer |
CMS (Group) |
Germany |
Zywottek, Walter W. (Merck KGaA –200807 before VWR president and CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
Zürcher, Thomas (Formune S.L. 201504 CEO) |
Chief Executive Officer (CEO) |
ForMune S.L. |
Spain (España) |
Zypries, Brigitte (Germany (govt) 200809 Minister of Justice) |
Minister |
Germany (govt) |
Germany |
Zünkeler, Martin (Kairos GmbH 201203 Managing Director) |
Managing Director |
Iqvia (Group) |
Germany |
Zündorf, Peter (Schering 2005– before Aventis Pharma before RPR + Bayer) |
n. a. |
Bayer (Group) |
Germany |
Zydron, Miroslawa (Selvita 201602 Director of Contract Chemistry Dept + Member of Management Board) |
Board member, executive |
Selvita (Group) |
Poland |
Zwirs, Ben (Philips 202008 Global Press Officer) |
Public Relations Manager / Investor Relations Manager |
Philips (Group) |
Netherlands |
Zwighaft, Ziv (Ambrosia Bio 202206 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Ambrosia Bio (IL) |
Israel |
Zwicker, Jörk (ZSP Patentanwälte 201704 Partner beore Boehmert & Boehmert) |
Patent Attorney |
ZSP Patentanwälte (Zwicker Schnappauf & Partner Patentanwälte PartG mbB) |
Germany |
Zwick, Jordan (Mirador Therapeutics 202403 CBO formerly InflaRx before Salix + Medtronic) |
Business Development Manager / Strategy Manager |
Mirador Therapeutics Inc. |
United States (USA) |
Zweifach, Sanford S. (Sandy) (Pathway Diagnostics 200503 CEO) |
Chief Executive Officer (CEO) |
Pathway Diagnostics Corporation |
United States (USA) |
Zwanziger, Ron (Alere/Inverness Medical 200603–201406 CEO RESIGNED 7/14) |
Chief Executive Officer (CEO) |
Abbott (Group) |
United States (USA) |
Zwaal, Marcel (Gadeta 202310 CEO before Kiadis + Hubrecht Organoid + Galapagos + DCPrime + Crucell) |
Chief Executive Officer (CEO) |
Kiadis (Group) |
Netherlands |
Zviran, Asaf (C2i Genomics 202006 CEO + CSO + Co-Founder) |
Chief Executive Officer (CEO) |
C2i Genomics Inc. |
United States (USA) |
Zurlo, Alfredo (Glycotope 201604– CMO before Mologen 201304– CMO before Roche + EORTC) |
Chief Medical Officer (CMO) |
Glycotope (Group) |
Germany |
Zurek Gabriela (Bruker Biosciences 2006 Bruker Daltonik GmbH Application Scientist) |
n. a. |
Bruker (Group) |
Germany |
Zurdo, Jesús (Rentschler 201911 SVP Innovation + Venture Partnerships) |
n. a. |
Rentschler (Group) |
Germany |
zur Hausen, Jan Dirk (Bergmann zur Hausen 201210 Managing Director + Co-founder) |
Managing Director |
Bergmann zur Hausen & Cie. GmbH |
Germany |
zur Hausen, Harald |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Zupancic, Klemen (Biosistemika 201201 CEO) |
Chief Executive Officer (CEO) |
BioSistemika d.o.o. |
Slovenia |
Zundel, Stefan (Dopavision 201809– Managing Director + Co-Founder) |
Managing Director |
Dopavision GmbH |
Germany |
Zumbrum, Michael (AllPure Technologies 201404 President) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
United States (USA) |
Zumbansen, Markus (Ayoxxa 201407– VP RnD before Miltenyi Biotec) |
Research & Development Manager |
Ayoxxa (Group) |
Germany |
Zuliani, Vincent (GenoSafe 201611 Business Development Director) |
Business Development Manager / Strategy Manager |
GenoSafe SAS |
France |
Zuckerman, Linda (Evotec 202209 EVP Global Head Biotherapeutics at Just – Evotec Biologics) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
United States (USA) |
Zucker, Maximilian (Numares 201702 Executive Board Member + Head RnD) |
Board member, executive |
Numares (Group) |
Germany |
Zucchelli, Piero (Andrew Alliance 201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Waters (Group) |
Switzerland |
Zuber, Johannes (IMP Vienna 2011– Group Leader + Quantro Therapeutics 202007 Co-Founder + Scientific Advisor) |
Researcher (university / research institute) |
Boehringer Ingelheim (Group) |
Austria |
Zubarev, Roman A. (Karolinska Instutet 201005 Professor before Univ Uppsala 200712 Professor) |
Professor |
Karolinska Institutet |
Sweden |
Zsebo, Krisztina (Celladon Corp 201411 CEO) |
Chief Executive Officer (CEO) |
Celladon Corporation |
United States (USA) |
Zou, Johnny (Primavera Capital 202109 at Primavera Venture Partners) |
Investment Manager |
Primavera Capital (Group) |
China |
Zoro, Barney (Sartorius 201803 ambr Product Manager at SSB) |
Product Manager (personnel) |
Sartorius (Group) |
Germany |
Zori, Ron (Essential Capital 202311) |
Investment Manager |
Essential Capital (US, NY) |
United States (USA) |
Zorbas, Haralabos (Bayern (govt) 201307 Managing Director of IBB Netzwerk GmbH) |
Managing Director |
Bavaria (govt region) |
Germany |
Zook, Tony (AstraZeneca –201301 EVP Global Commercial LEFT 1/13 before CEO of AstraZeneca USA) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
Zoltobrocki, Manfred (PKCie 200604– Senior Consultant before Lux Biosciences GmbH + Epidaurus AG) |
Consultant (economic/technology) |
PKCie – Prof. Köpper & Cie Management Consultants GbR |
Germany |
Zollner, Stanislava (Helmholtz 202008 at Ascenion GmbH) |
Public Relations Manager / Investor Relations Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
Zoller, Jessica (France (govt) 202004 Life Science Analyst at Bpifrance) |
Analyst (Financial / Industry) |
France (govt) |
France |
Zolghadr, Kourosh (ChromoTek 201403 Head of RnD) |
Research & Development Manager |
Proteintech (Group) |
Germany |
Zohar, Daphne (Seaport Therapeutics 202404– CEO + Co-Founder before PureTech Health CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Seaport Therapeutics (US) |
United States (USA) |
Zocco, Giuseppe (Medicxi 201706 Partner before Index Ventures Co-Founder) |
Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
Zocca, Mai-Britt (IO Biotech ApS 201601 CEO + Founder) |
Chief Executive Officer (CEO) |
IO Biotech (Group) |
Denmark |
Zobel, Peter Hanns (Bayern (govt) 1995–202403 Managing Director at IZB LEFT 3/24) |
Managing Director |
Bavaria (govt region) |
Germany |
Znaty, David (ScreenCell 201205 CEO) |
Chief Executive Officer (CEO) |
ScreenCell (FR) |
France |
Ziwica, Marcel (Zur Rose Group 202007 CFO) |
Chief Financial Officer (CFO) |
Zur Rose Group (Group) |
Switzerland |
Ziv, Tamar (Technion 201008 Manager Smoler Proteomics Center) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Technion – Israel Institute of Technology |
Israel |
Zisman, Einat (FutuRx 201705 CEO + Hadassah 201309 CEO of Hadasit) |
Chief Executive Officer (CEO) |
Hadassah (HMO) (Group) |
Israel |
Zisapel, Zohar |
n. a. |
|
|
Zirngibl, Carmen (DCZ Executive Search 202312 + FS Life Science Investment) |
Managing Partner |
DCZ Executive Search GmbH |
Germany |
Zippelius, Peter (Leonard Green & Partners 201904 Partner) |
Partner (venture partner) |
Leonard Green & Partners L.P. (LGP) |
United States (USA) |
Zipp, Keely Beck (Lava Therapeutics 202010– VP Corporate Development + Portfolio Strategy) |
Business Development Manager / Strategy Manager |
Lava Therapeutics (Group) |
Netherlands |
Zipkin, Mark (IB Communicsion 202212) |
Public Relations Manager / Investor Relations Manager |
Image Box Ltd. (Image Box PR / IB Communications) |
United Kingdom (GB) |
Ziolkowski, Marek (A.G.A. Analytical 201108 Dyrektor handlowy) |
President/Director/Head Business Group/Unit/Division |
A.G.A. Analytical |
Poland |
Zinsser-Noethen, Wiebke (Zinsser Analytic 200809) |
Sales Manager / Marketing Manager |
KKR (Kohlberg Kravis Roberts) (Group) |
Germany |
Zinsser, Werner (Zinsser Analytic 200808 Managing Director) |
Managing Director |
KKR (Kohlberg Kravis Roberts) (Group) |
Germany |
Zins, Antoine (Eurazeo 202004 Investment Manager at Idinvest Partners) |
Investment Manager |
Eurazeo (Group) |
France |
Zinke, Holger (BRAIN 201507– Supervisory Board Member before CEO) |
Supervisory Board Member |
BRAIN Biotech (Group) |
Germany |
Zink, Barbara (Basilea 201109 Head Corporate Development) |
Business Development Manager / Strategy Manager |
Basilea (Group) |
Switzerland |
Zinggrebe, Achim (Syneed Medidata GmbH 201305 Managing Director) |
Managing Director |
Syneed Medidata GmbH |
Germany |
Zimmermann, Sven (Novimmune 201609– CFO before Auris Medical + PregLem + UBS Investment Bank) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Switzerland |
Zimmermann, Sabrina (BMG Labtech 201110 Sales Assistant BMG Labtech GmbH) |
Sales Manager / Marketing Manager |
BMG Labtech (Group) |
Germany |
Zimmermann, Ralf (Helmholtz-Zentrum München + Univ Rostock) |
Professor |
University of Rostock |
Germany |
Zimmermann, Philip (Nebion 201801 CEO) |
Chief Executive Officer (CEO) |
Immunai (Group) |
Switzerland |
Zimmermann, Julia (Terraplasma 202210 Managing Director (CEO)) |
Managing Director |
Terraplasma (Group) |
Germany |
Zimmermann, Jens (Adrenomed 2017– CMO before Vanda Pharmaceuticals + Roche + InterMune + Pfizer + Shire + Jerini) |
Chief Medical Officer (CMO) |
Adrenomed AG |
Germany |
Zimmermann, Holger (AiCuris 202304– Chief Research + Development Officer before CEO before CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
STRÜNGMANN Group (family Strüngmann) |
Germany |
Zimmermann, Heiko (Fraunhofer 201402 Head of Fraunhofer IBMT) |
President/Director/Head Business Group/Unit/Division |
Fraunhofer (Group) |
Germany |
Zimmermann, Frank (Biomax Informatics 201710 Director Business Development) |
Business Development Manager / Strategy Manager |
Biomax (Group) |
Germany |
Zimmermann, Elke |
n. a. |
Bremen (govt region) |
Germany |
Zimmermann, Dirk (Biocartis 201905– Global Head Pharma Collaborations + Partnering before Roche Diagnostics + Qiagen) |
Business Development Manager / Strategy Manager |
Biocartis (Group) |
Belgium |
Zimmermann, Cyrill (Bellevue Group 201409 CEO of Adamant Biomedical Investments AG) |
Chief Executive Officer (CEO) |
Bellevue (Group) |
Switzerland |
Zimmermann, Bastian (Biaffin 201110 Managing Director) |
Managing Director |
Biaffin (Group) |
Germany |
Zimmerman, Zachary A. (Forge Therapeutics 201612 CEO) |
Chief Executive Officer (CEO) |
Forge Therapeutics Inc. |
United States (USA) |
Zimmerman, Terresa (Innovaro 201003 VP Marketing) |
Sales Manager / Marketing Manager |
Inpart (Group) |
United States (USA) |
Zimmer, Thomas (AMP Biosimilars 201505– Supervisory Board Chairman formerly at Boehringer Ingelheim) |
Supervisory Board Member |
AMP Biosimilars AG |
Germany |